Two Interconvertible Folds Modulate the Activity of a DNA Aptamer Against Transferrin Receptor

Thanks to their ability to recognize biomolecular targets with high affinity and specificity, nucleic acid aptamers are increasingly investigated as diagnostic and therapeutic tools, particularly when their targets are cell-surface receptors. Here, we investigate the relationship between the folding...

Full description

Bibliographic Details
Main Authors: David Porciani, Giovanni Signore, Laura Marchetti, Paolo Mereghetti, Riccardo Nifosì, Fabio Beltram
Format: Article
Language:English
Published: Elsevier 2014-01-01
Series:Molecular Therapy: Nucleic Acids
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2162253116302839
_version_ 1819242054521192448
author David Porciani
Giovanni Signore
Laura Marchetti
Paolo Mereghetti
Riccardo Nifosì
Fabio Beltram
author_facet David Porciani
Giovanni Signore
Laura Marchetti
Paolo Mereghetti
Riccardo Nifosì
Fabio Beltram
author_sort David Porciani
collection DOAJ
description Thanks to their ability to recognize biomolecular targets with high affinity and specificity, nucleic acid aptamers are increasingly investigated as diagnostic and therapeutic tools, particularly when their targets are cell-surface receptors. Here, we investigate the relationship between the folding of an anti-mouse transferrin receptor DNA aptamer and its interaction with the transferrin receptor both in vitro and in living cells. We identified and purified two aptamer conformers by means of chromatographic techniques. Fluorescence-anisotropy measurements showed that only one fold is able to bind mouse transferrin receptor. Besides displaying enhanced endocytosis in living mouse fibroblasts, the purified active fold is internalized also in human pancreatic cancer cells. Starting from these observations, we rationally designed variations of the parent sequence aimed at stabilizing the active fold, and consequently increase aptamer activity. A truncated version and full-length mutants with higher affinity than the parent sequence are shown.
first_indexed 2024-12-23T14:33:42Z
format Article
id doaj.art-e8a536d5c7fd40dfb4dc991ee23e9618
institution Directory Open Access Journal
issn 2162-2531
language English
last_indexed 2024-12-23T14:33:42Z
publishDate 2014-01-01
publisher Elsevier
record_format Article
series Molecular Therapy: Nucleic Acids
spelling doaj.art-e8a536d5c7fd40dfb4dc991ee23e96182022-12-21T17:43:26ZengElsevierMolecular Therapy: Nucleic Acids2162-25312014-01-013C10.1038/mtna.2013.71Two Interconvertible Folds Modulate the Activity of a DNA Aptamer Against Transferrin ReceptorDavid Porciani0Giovanni Signore1Laura Marchetti2Paolo Mereghetti3Riccardo Nifosì4Fabio Beltram5NEST, Scuola Normale Superiore and Istituto Nanoscienze-CNR, Pisa, ItalyCenter for Nanotechnology Innovation@NEST, Istituto Italiano di Tecnologia, Pisa, ItalyNEST, Scuola Normale Superiore and Istituto Nanoscienze-CNR, Pisa, ItalyCenter for Nanotechnology Innovation@NEST, Istituto Italiano di Tecnologia, Pisa, ItalyNEST, Scuola Normale Superiore and Istituto Nanoscienze-CNR, Pisa, ItalyNEST, Scuola Normale Superiore and Istituto Nanoscienze-CNR, Pisa, ItalyThanks to their ability to recognize biomolecular targets with high affinity and specificity, nucleic acid aptamers are increasingly investigated as diagnostic and therapeutic tools, particularly when their targets are cell-surface receptors. Here, we investigate the relationship between the folding of an anti-mouse transferrin receptor DNA aptamer and its interaction with the transferrin receptor both in vitro and in living cells. We identified and purified two aptamer conformers by means of chromatographic techniques. Fluorescence-anisotropy measurements showed that only one fold is able to bind mouse transferrin receptor. Besides displaying enhanced endocytosis in living mouse fibroblasts, the purified active fold is internalized also in human pancreatic cancer cells. Starting from these observations, we rationally designed variations of the parent sequence aimed at stabilizing the active fold, and consequently increase aptamer activity. A truncated version and full-length mutants with higher affinity than the parent sequence are shown.http://www.sciencedirect.com/science/article/pii/S2162253116302839aptamer foldingaptamer-mediated endocytosisaptamer rational engineeringtransferrin receptor
spellingShingle David Porciani
Giovanni Signore
Laura Marchetti
Paolo Mereghetti
Riccardo Nifosì
Fabio Beltram
Two Interconvertible Folds Modulate the Activity of a DNA Aptamer Against Transferrin Receptor
Molecular Therapy: Nucleic Acids
aptamer folding
aptamer-mediated endocytosis
aptamer rational engineering
transferrin receptor
title Two Interconvertible Folds Modulate the Activity of a DNA Aptamer Against Transferrin Receptor
title_full Two Interconvertible Folds Modulate the Activity of a DNA Aptamer Against Transferrin Receptor
title_fullStr Two Interconvertible Folds Modulate the Activity of a DNA Aptamer Against Transferrin Receptor
title_full_unstemmed Two Interconvertible Folds Modulate the Activity of a DNA Aptamer Against Transferrin Receptor
title_short Two Interconvertible Folds Modulate the Activity of a DNA Aptamer Against Transferrin Receptor
title_sort two interconvertible folds modulate the activity of a dna aptamer against transferrin receptor
topic aptamer folding
aptamer-mediated endocytosis
aptamer rational engineering
transferrin receptor
url http://www.sciencedirect.com/science/article/pii/S2162253116302839
work_keys_str_mv AT davidporciani twointerconvertiblefoldsmodulatetheactivityofadnaaptameragainsttransferrinreceptor
AT giovannisignore twointerconvertiblefoldsmodulatetheactivityofadnaaptameragainsttransferrinreceptor
AT lauramarchetti twointerconvertiblefoldsmodulatetheactivityofadnaaptameragainsttransferrinreceptor
AT paolomereghetti twointerconvertiblefoldsmodulatetheactivityofadnaaptameragainsttransferrinreceptor
AT riccardonifosi twointerconvertiblefoldsmodulatetheactivityofadnaaptameragainsttransferrinreceptor
AT fabiobeltram twointerconvertiblefoldsmodulatetheactivityofadnaaptameragainsttransferrinreceptor